Neoadjuvant radiochemotherapy with paclitaxel and carboplatin in patients with non-small-cell lung cancer (stage III) - A phase-II study

被引：0
|
作者：
Budach, W
Friedel, G
Hehr, T
Sepe, S
Hruska, D
Toomes, H
Dierkesmann, R
Bamberg, M
机构：
[1] Univ Tubingen, Radioonkol Klinikum, Tubingen, Germany
[2] Thoraxchirurg Schillerhohe Gerlingen, Gerlingen, Germany
[3] Pulmol Schillerhohe Gerlingen, Gerlingen, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2002年 / 178卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：19 / 19
页数：1
相关论文
共 50 条
  • [31] Neoadjuvant chemoradiotherapy of stage III non-small-cell lung cancer
    Friedel, G
    Hruska, D
    Budach, W
    Wolf, M
    Kyriss, T
    Hürtgen, M
    Eulenbruch, HP
    Dierkesmann, R
    Toomes, H
    LUNG CANCER, 2000, 30 (03) : 175 - 185
  • [32] Phase III trial comparing carboplatin, paclitaxel, and bexarotene with carboplatin and paclitaxel in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT II
    Blumenschein, George R., Jr.
    Khuri, Fadlo R.
    von Pawel, Joachim
    Gatzemeier, Ulrich
    Miller, Wilson H., Jr.
    Jotte, Robert M.
    Le Treut, Jacques
    Sun, Show-Li
    Zhang, Jinkun K.
    Dziewanowska, Zofia E.
    Negro-Vilar, Andres
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (11) : 1879 - 1885
  • [33] PHASE-II STUDY OF CARBOPLATIN IN NON-SMALL CELL LUNG-CANCER
    TAMURA, T
    SHINKAI, T
    EGUCHI, K
    SASAKI, Y
    FUJIWARA, Y
    FUKUDA, M
    OHE, Y
    NAKAGAWA, K
    MINATO, K
    SAIJO, N
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1989, 19 (01) : 51 - 55
  • [34] A phase II study of oxaliplatin and paclitaxel in patients with advanced non-small-cell lung cancer
    Winegarden, JD
    Mauer, AM
    Otterson, GA
    Rudin, CM
    Villalona-Calero, MA
    Lanzotti, VJ
    Szeto, L
    Kasza, K
    Hoffman, PC
    Vokes, EE
    ANNALS OF ONCOLOGY, 2004, 15 (06) : 915 - 920
  • [35] LONIDAMINE IN NON-SMALL-CELL LUNG-CANCER - A PHASE-II STUDY
    CONTU, A
    OLMEO, NA
    PANI, P
    DERIU, A
    ORTU, S
    PAGA, C
    TUMORI, 1991, 77 (01) : 52 - 55
  • [36] PHASE-II STUDY OF CONCURRENT RADIOTHERAPY AND CHEMOTHERAPY FOR UNRESECTABLE STAGE-III NON-SMALL-CELL LUNG-CANCER
    FURUSE, K
    KUBOTA, K
    KAWAHARA, M
    KODAMA, N
    OGAWARA, M
    AKIRA, M
    NAKAJIMA, S
    TAKADA, M
    KUSUNOKI, Y
    NEGORO, S
    MATSUI, K
    MASUDA, N
    TAKIFUJI, N
    KUDOH, S
    NISHIOKA, M
    FUKUOKA, M
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (04) : 869 - 875
  • [37] EPIRUBICIN IN PATIENTS WITH INOPERABLE NON-SMALL-CELL LUNG-CANCER - A PHASE-II STUDY
    NIIRANEN, A
    KAJANTI, M
    MATTSON, K
    PYRHONEN, S
    ACTA ONCOLOGICA, 1991, 30 (07) : 869 - 870
  • [38] Phase I/II investigation of paclitaxel, ifosfamide and carboplatin for advanced non-small-cell lung cancer
    Mauer, AM
    Ansari, RH
    Hoffman, PC
    Krauss, SA
    Taber, D
    Tembe, SA
    Gabrys, GT
    Cotter, T
    Schumm, LP
    Szeto, L
    Vokes, EE
    ANNALS OF ONCOLOGY, 2003, 14 (05) : 722 - 728
  • [39] Paclitaxel/carboplatin in the treatment of non-small-cell lung cancer
    Belani, CP
    ONCOLOGY-NEW YORK, 1998, 12 (01): : 74 - 79
  • [40] PACLITAXEL AND CARBOPLATIN IN COMBINATION IN THE TREATMENT OF ADVANCED NON-SMALL-CELL LUNG-CANCER - A PHASE-II TOXICITY, RESPONSE, AND SURVIVAL ANALYSIS
    LANGER, CJ
    LEIGHTON, JC
    COMIS, RL
    ODWYER, PJ
    MCALEER, CA
    BONJO, CA
    ENGSTROM, PF
    LITWIN, S
    OZOLS, RF
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (08) : 1860 - 1870
12345